Protecting Kids from Pneumonia Alexandria VA

The current recommended dose schedule for 7-valent pneumococcal conjugate vaccine (PCV-7) consists of three primary doses before the age of 6 months, followed by a booster vaccination in the second year of life (3 + 1-dose schedule) in Alexandria.

Dancel Rosario G MD
(703) 823-2400
6000 Stevenson Avenue Suite 104
Alexandria, VA
 
Juan Reynaldo Fraga, MD
(703) 370-6862
4518 Seminary Rd
Alexandria, VA
Specialties
Pediatrics
Gender
Male
Education
Medical School: Inst Sup De Cien Med De La Habana, La Habana, Cuba
Graduation Year: 1950

Data Provided by:
Dr. Michael James Hopper
(703) 642-1100
6355 Walker Ln Ste 401
Alexandria, VA
Specialty
Pediatrics

Nancy J Leykam
(703) 971-6900
7015c Manchester Blvd
Alexandria, VA
Specialty
Adolescent Medicine

Data Provided by:
Park Sue Y
(703) 212-6600
4660 Kenmore Avenue
Alexandria, VA
 
Kingstown Family Practice
(703) 922-4601
6206 Old Franconia Road
Alexandria, VA
 
Samantha W Ahdoot
(703) 924-2100
6355 Walker Lane
Alexandria, VA
Specialty
Pediatrics

Data Provided by:
Field Laraine T MD
(703) 922-6161
6412 Beulah Street
Alexandria, VA
 
Lilia G Butler, MD
(703) 504-3000
4320 Seminary Rd
Alexandria, VA
Specialties
Pediatrics
Gender
Female
Education
Medical School: Univ Of The East, Ramon Magsaysay Mem Med Ctr, Quezon City
Graduation Year: 1965

Data Provided by:
Eugenia Lin
(703) 971-6900
7015c Manchester Blvd
Alexandria, VA
Specialty
Pediatrics

Data Provided by:
Data Provided by:

Protecting Kids from Pneumonia

Provided By:

Parents and babies alike will be relieved by new findings that show a reduced-dose schedule for the pneumococcal vaccine can protect infants against pneumonia and other infections.

The current recommended dose schedule for 7-valent pneumococcal conjugate vaccine (PCV-7) consists of three primary doses before the age of 6 months, followed by a booster vaccination in the second year of life (3 + 1-dose schedule). But factors such as questions about the cost-effectiveness of the current PCV-7 dose schedule have led researchers to examine reduced-dose vaccine schedules, according to background information in the study.

The researchers, Dr. Elske J.M. van Gils, of the University Medical Center Utrecht in the Netherlands, and colleagues, studied 1,003 healthy infants who were randomly assigned to receive two doses of PCV-7 at 2 months and 4 months of age, or a 2 + 1-dose schedule at 2, 4 and 11 months of age, or no vaccine (control group). The children were checked after 12 months, 18 months and 24 months for pneumococcal microorganisms in the upper part of the throat behind the nose.

Compared to those in the control group, children in both vaccine groups had far lower rates of microorganisms that can cause pneumonia and other infections, according to the report in the July 8 issue of the Journal of the American Medical Association.

"In conclusion, both two-dose and 2 + 1-dose schedules of PCV-7 significantly reduce vaccine serotype pneumococcal carriage in children. This study supports future implementation of reduced-dose PCV-7 schedules," the researchers concluded.

More information

The Nemours Foundation has more about children and pneumonia.

SOURCE: Journal of the American Medical Association, news release, July 7, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com